DrugPatentWatch Database Preview
Custopharm Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for CUSTOPHARM INC, and what generic and branded alternatives to CUSTOPHARM INC drugs are available?
CUSTOPHARM INC has seven approved drugs.
Summary for Custopharm Inc
| US Patents: | 0 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 7 |
| Patent Litigation for Custopharm Inc: | See patent lawsuits for Custopharm Inc |
Drugs and US Patents for Custopharm Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Custopharm Inc | SODIUM TETRADECYL SULFATE | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 209937-001 | Dec 9, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Custopharm Inc | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | INJECTABLE;INJECTION | 210788-001 | Feb 11, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Custopharm Inc | VALRUBICIN | valrubicin | SOLUTION;INTRAVESICAL | 206430-001 | Apr 19, 2019 | AO | RX | No | No | Start Trial | Start Trial | ||||
| Custopharm Inc | ACETAMINOPHEN | acetaminophen | SOLUTION;INTRAVENOUS | 202605-001 | Jun 13, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
